Talha Badar

84PUBLICATIONS
299CO-AUTHORS
Gene and molecular therapyHaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cell and nuclear division
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (84)

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Jun 09, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.

|Jun 02, 2026
Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.

|Apr 09, 2026
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Razan Mohty, Ravi Narra, Alice S Mims

|Apr 06, 2026
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients.

Saubia Fathima, Lior Rokach, Nour Ghosoun

|Mar 31, 2026
Rapid germ line testing with hair root bulb-derived DNA for hereditary predisposition and inherited marrow failure states.

Emma C St Martin, Abhishek A Mangaonkar, Ann M Moyer

Pageof 14

Frequent Collaborators

31 joint publications

Naseema Gangat

28 joint publications

Mark R Litzow

27 joint publications

Mrinal Patnaik

25 joint publications

Mithun Vinod Shah